Based on recent data, Deciphera Pharmaceuticals, Inc. (DCPH) shows an Average True Range (ATR) of 0.2 and an Enterprise Value of 1.12B. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into DCPH's underlying financial health and market activity.
| ATR | 0.2 |
| Enterprise Value | 1.12B |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Deciphera Pharmaceuticals, Inc. (DCPH) technical indicators as of June 23, 2026: the SMA 20 is 0.32%, SMA 50 at 20.33%, and SMA 200 at 61.93%. The RSI 14 value is 85.58, suggesting its current momentum. These technical analysis signals help assess DCPH's price trends and potential future movements.
| SMA 20 | 0.32% |
| SMA 50 | 20.33% |
| SMA 200 | 61.93% |
| RSI 14 | 85.58 |
Deciphera Pharmaceuticals, Inc. (DCPH) stock performance overview as of June 23, 2026: The 52-week high is N/A (currently -0.08% below), and the 52-week low is N/A (currently 158.48% above). Over the past year, DCPH's performance is N/A, compared to the S&P 500's 10.67% change.
| 52-Week High | N/A |
| 52-Week High Chg | -0.08% |
| 52-Week Low | N/A |
| 52-Week Low Chg | +158.48% |
| S&P 500 52-Week Chg | 10.67% |
According to market data, Deciphera Pharmaceuticals, Inc. (DCPH) stock's recent performance metrics show that over the last month, DCPH is 0.91%, with a Year-to-Date (YTD) performance of 58.65%. Over the past year, the stock has seen a N/A change. These figures summarize DCPH's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | N/A | N/A | N/A | N/A | N/A | N/A |
| Low | N/A | N/A | N/A | N/A | N/A | N/A |
| Performance | +0.08% | +0.91% | +59.04% | +72.91% | - | +58.65% |
According to current financial data, DCPH stock's P/E (TTM) ratio is -11.17, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for DCPH, including P/S (13.55), P/B (6.20), and P/FCF (-15.01), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | DCPH | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -11.17 | -1.22 | 12.85 | 32.59 |
| P/S (TTM) | 13.55 | 3.69 | 6.17 | 5.98 |
| P/B (TTM) | 6.2 | 0.04 | 44.37 | 5 |
| P/FCF (TTM) | -15.01 | -4.17 | 3.79 | 28.32 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep